Registered number: 12343488

Anatomy Investment Research Ltd
Unaudited Financial Statements
for the period ended 28 February 2025

Statement of Financial Position

as at 28 February 2025

  2025
Restated
2024
   
££
 
££
Called up share capital not paid  
  -  
 
  -  
Fixed assets  
  -  
 
  -  
Current assets  
535    
 
124    
Prepayments and accrued income  
-    
 
-    
Creditors: amounts falling due within one year  
( 2,179 )  
 
-    
Net current assets (liabilities)  
  ( 1,644 )
 
  124  
Total assets less current liabilities  
  ( 1,644 )
 
  124  
Creditors: amounts falling due after more than one year  
  -  
 
  -  
Provisions for liabilities  
  -  
 
  -  
Accruals and deferred income  
  -  
 
  -  
Net assets  
  ( 1,644 )
 
  124  
   
Capital and reserves  
  ( 1,644 )
 
  124  

xbrli:pure 12343488 2024-07-01 2025-02-28 12343488 2023-07-01 2024-06-30 12343488 2025-02-28 12343488 2024-06-30 12343488 2024-07-01 12343488 uk-frs102:WithinOneYear 2025-02-28 12343488 uk-frs102:AfterOneYear 2025-02-28 12343488 uk-frs102:WithinOneYear 2024-06-30 12343488 uk-frs102:AfterOneYear 2024-06-30 12343488 uk-bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-02-28 12343488 uk-bus:FilletedAccounts 2024-07-01 2025-02-28 12343488 uk-bus:Director1 1 2024-07-01 2025-02-28 12343488 uk-bus:Director1 2024-07-01 2025-02-28 12343488 uk-bus:Director1 1 2024-07-01 12343488 uk-bus:Director1 1 2025-02-28 12343488 uk-bus:Micro-entities 2024-07-01 2025-02-28 12343488 uk-bus:PrivateLimitedCompanyLtd 2024-07-01 2025-02-28 iso4217:GBP 12343488 countries:EnglandWales 2024-07-01 2025-02-28 12343488 uk-bus:RegisteredOffice 2024-07-01 2025-02-28

Footnotes to the Statement of Financial Position

Dexu Qu

1. Arrangements not included in Statement of Financial Position

The company has not entered into any arrangements not shown on the Statement of Financial Position.

2. Average number of employees

The average number of employees in the period was 1.

3. Directors’ benefits: advances, credit and guarantees

Dexu Qu

Included in creditors is an amount due to be paid by the company to one of its directors. The amount is an advance made to the company of £2,179 by Dexu Qu, a director of the company, on 16/08/2024.

During the accounting period the maximum amount repayable to Dexu Qu was £2,179

The following conditions are attached to amount payable to Dexu Qu:

  • There is no interest due to be paid on any outstanding amount
  • No fixed date has been set for the amount to be repaid by the company.
Opening balance 01/07/2024 Additional advance Amount repaid Amount written off Amounts waived Interest payable Closing balance 28/02/2025
£ £ £ £ £ £ £
( 80 ) ( 1,196 )
( 1,196 )
3,455
3,455  
0 0 0 2,179  

4. Guarantees, contingencies and other financial commitments

There are no guarantees, contingencies or other commitments not included in the financial statements.

Statutory Statements

In accordance with section 414(3) of the Companies Act 2006, these accounts have been prepared in accordance with the FRS 105: The Financial Reporting Standard applicable to the Micro-entities Regime for periods commencing on or after 1 January 2016. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

For the period ending 28/02/2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of Companies Act 2006 with respect to accounting records and the preparation of accounts

Company information

a) The company is registered in England and Wales

b) Company registration number - 12343488

c) The company is a private company and is limited by shares

d) The company's registered office address is Flat 3 Brunswick House Balcombe Street, London, NW1 6NG, England

e) Company ceased to trade on 28/02/2025



Approved by the board of directors and signed on behalf of the board,

Anatomy Investment Research Ltd
Director Dexu Qu
Date of approval: 08/05/2025
The company was trading for the entire period 2024-07-01 2025-02-28 2025-02-28 Business consulting services and company research services 2025-05-08 2025-05-08